Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%.stock performance was -7.00% in last session and finished the … Continue reading Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Groupon, Inc. (NASDAQ:GRPN), Renewable Energy Group, Inc. (NASDAQ:REGI), Natural Alternatives International (NASDAQ:NAII), TD Ameritrade (NYSE:AMTD)

On Nov. 13, Ocera Therapeutics, Inc. (NASDAQ:OCRX) announced recent business highlights and reported financial results for the quarter ended September 30, 2014. As of September 30, 2014, Ocera had cash, cash equivalents and investments of $55.6 million. Net loss for the three and nine months ended September 30, 2014 was $6.6 million and $17.9 million, respectively. Ocera Therapeutics, Inc. (NASDAQ:OCRX) belongs to Healthcare sector. Its … Continue reading Eye Catching Stocks: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Groupon, Inc. (NASDAQ:GRPN), Renewable Energy Group, Inc. (NASDAQ:REGI), Natural Alternatives International (NASDAQ:NAII), TD Ameritrade (NYSE:AMTD)

Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

In June, Esperion Therapeutics Inc. (NASDAQ:ESPR), an Ann Arbor-based early-stage pharmaceutical company, raised $73 million in its IPO. It plans a secondary offering this year, based on trial results of its cholesterol-lowering drug. Esperion Therapeutics Inc (NASDAQ:ESPR) stock performance was -5.04% in last session and finished the day at $14.69. Traded volume was 31,400 shares in the last session and the average volume of the … Continue reading Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ:NETE), Lumber Liquidators (NYSE:LL), Ocera Therapeutics Inc (NASDAQ:OCRX)

Potbelly Corp. (NASDAQ:PBPB), the hot-sandwich seller that went public nine months ago, dropped the most since its October initial public offering after its annual profit forecast and quarterly sales trailed analysts’ estimates. Potbelly Corp (NASDAQ:PBPB) stock performance was -25.12% in last session and finished the day at $10.97. Traded volume was 7.27million shares in the last session and the average volume of the stock remained … Continue reading Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ:NETE), Lumber Liquidators (NYSE:LL), Ocera Therapeutics Inc (NASDAQ:OCRX)

Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera Therapeutics (NASDAQ:OCRX), MediciNova (NASDAQ:MNOV), PTC Therapeutics (NASDAQ:PTCT)

Registrant and three of its wholly-owned subsidiaries, Reliv, International, Inc (NASDAQ:RELV), Reliv World Corporation and SL Technology, Inc. entered into a Credit Agreement with BMO Harris Bank N.A. (the “Bank”) pursuant to which the Bank agreed to provide certain credit facilities to Registrant, including a Term Loan in the principal amount of $3,481,961 and a revolving credit facility in the amount of $5,000,000. Reliv International, … Continue reading Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera Therapeutics (NASDAQ:OCRX), MediciNova (NASDAQ:MNOV), PTC Therapeutics (NASDAQ:PTCT)

Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Escalon Medical Corp. (NASDAQ:ESMC) trades at a significant discount to its peer group as the lack of investor (and analyst) following results in the successful “shrink to grow” strategy being ignored. The company is now a pure play with no debt, cash that represents ~20% of the market cap, overlooked tax assets and a significantly lower cash burn rate. Escalon Medical Corp. (NASDAQ:ESMC) stock performance … Continue reading Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)